HFS
UTHR icon

Hantz Financial Services’s United Therapeutics UTHR Stock Holding History

Hantz Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
2,278
+6
+0.3% +$3.38K 0.02% 455
2026
Q1 		$1.35M Buy
2,272
+702
+45% +$350K 0.02% 425
2025
Q4 		$765K Buy
1,570
+629
+67% +$293K 0.01% 530
2025
Q3 		$394K Buy
941
+695
+283% +$234K 0.01% 596
2025
Q2 		$71K Buy
246
+234
+1,950% +$69.9K ﹤0.01% 850
2025
Q1 		$4K Buy
+12
New +$4.11K ﹤0.01% 1245

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hantz Financial Services's UTHR Position: Q2 2026 in Review

Hantz Financial Services increased its United Therapeutics (UTHR) stake by 0.26% in Q2 2026, buying an estimated $3.38K and bringing the position to 2,278 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #455.

Hantz Financial Services first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.35M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hantz Financial Services held 2,278 shares of United Therapeutics worth $1.23M as of Q2 2026.
  • Hantz Financial Services bought 6 United Therapeutics shares in Q2 2026, an estimated $3.38K.
  • United Therapeutics made up 0.02% of Hantz Financial Services's portfolio in Q2 2026, its #455 holding.
  • Hantz Financial Services first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's United Therapeutics position peaked at $1.35M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.